网站大量收购闲置独家精品文档,联系QQ:2885784924

FDA工艺分析技术.pdf

  1. 1、本文档共20页,可阅读全部内容。
  2. 2、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
FDA工艺分析技术

Can Pharmaceutical Industry Ignore PAT? Matt Safi Eurotherm Life Science group October 2005 Agenda • What is wrong with Pharmaceutical Manufacturing today • Is PAT the solution? • Can Pharmaceutical industry ignore PAT? Pharmaceutical Manufacturing Today What is Wrong today? • Pressure on prices • Low utilization 30 - 40 % on average • Excessive amounts of product non-conformances • Long lead-times due to stage and final product testing • Capital and labor intensive • High operating costs • High inventories and excessive warehouse capacity Typical Pharmaceutical Process life Cycle 20 Days Final Film Blend Coating Granulation Step Raw Chemical Processing Blend 1 Compress Packaging Material weighing QC1 QC2 QC3 •Particle Size •Description •API •Load •ID 10 Days •Assay 15 Days •Impurity •Dissolution W hat is wrong today? • Most processes are fixed with variable materials, resulting in variable quality of product. • Most processes are not well understood. • Existing procedural approach has created a “climate of fear” stifling innovation .

文档评论(0)

jgx3536 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:6111134150000003

1亿VIP精品文档

相关文档